TSS Receives CDP SME Climate Score 'SME B' for Strong Climate Actions

A technician assembles a temperature data logger.
TSS, a global company specializing in temperature monitoring for the pharmaceutical supply chain, is proud to announce that it has received an 'SME B' rating from the 2024 CDP SME Climate Score. This recognition highlights TSS’s commitment to being open about its environmental impact and taking steps to reduce it.
PRESS RELEASE, 4 March 2025

The CDP SME Climate Score measures how small and medium-sized businesses manage and share their climate-related information. It follows global standards like the Task Force on Climate-Related Financial Disclosures (TCFD) and IFRS S2 Climate-related Disclosures. Earning an 'SME B' score means that TSS has put strong environmental plans in place and is actively working to lower its carbon footprint.

“At TSS, we believe that sustainability is a key part of the pharmaceutical supply chain’s future,” said Lie Berglind, Chief Quality Officer at TSS. “This recognition from CDP shows that we are making real progress in reducing our environmental impact. Our customers can trust that we are committed to building a greener pharma supply chain. By using data-driven solutions, we continue to improve efficiency and cut emissions.”

TSS will keep working on new sustainability efforts, aligning with global climate goals, and helping customers meet their own environmental targets.

__wf_reserved_inherit

About CDP SME Climate Score

CDP is a global non-profit that runs the world’s only independent environmental disclosure system. As the founder of environmental reporting, we believe in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, we surface the information needed to enable Earth-positive decisions. We helped more than 24,800 companies and 1,100 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world’s institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB’s climate standard, IFRS S2, as its foundational baseline, CDP integrates best-practice reporting standards and frameworks in one place. Our team is truly global, united by our shared desire to build a world where people, planet and profit are truly balanced. Visit CDP.net or follow us @CDP to find out more.

About TSS

TSS is a temperature control monitoring and supply chain solutions provider serving the life science and pharmaceutical industry globally. With headquarters in Sweden, TSS have 30 years of experience providing a compliance baseline in hosting GxP Data and GxP validated SaaS to life science companies.

TSS aims to assure safe drugs for every patient by transforming the global pharmaceutical supply chain through an industry leading cloud temperature management solutions. Working in partnership with pharmaceutical companies, TSS provide advanced monitoring and analytics tools to help our client's meet compliance, implement lean and sustainable supply chains, and deliver drugs safely.

Contact

Tobias Holmer
Chief Executive Officer, TSS
tobias.holmer@tss.se

For media inquiries:

Josefin Malmgren
Head of Marketing & Communication, TSS
josefin.malmgren@tss.se

You may also be interested in

A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read moreDownload Whitepaper

Mind the gap: the real-world impact of data gaps in clinical trials

Although clinical trials can cover a huge range of formats, from small academic assessments to global, multi-billion dollar ventures, they all have one thing in common. Their success (or failure) is determined by a consistent approach to data.
Read moreDownload Whitepaper
The assembly of a data logger, representing TSS's commitment to innovation and digitalisation for WTISD 2024.

TSS Celebrates WTISD 2024: Embracing Innovation, Digitalisation, and Sustainability

World Telecommunication & Information Society Day (WTISD), celebrated annually on May 17th, highlights the pivotal role of digital technologies in fostering societal progress. This day serves as a reminder of the transformative power of innovation and digitalisation in building a sustainable future. At TSS, we are dedicated to leveraging advanced technologies to enhance the pharmaceutical supply chain while promoting sustainability.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.